시장보고서
상품코드
1941263

신경외과용 의료기기 시장 보고서 : 제품 유형별, 용도별, 최종사용자별, 지역별(2026-2034년)

Neurosurgery Devices Market Report by Product Type (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid Management Devices, and Others), Application, End-User, and Region 2026-2034

발행일: | 리서치사: IMARC | 페이지 정보: 영문 144 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신경외과용 의료기기 시장 규모는 2025년에 142억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 331억 달러에 달하고, 2026년부터 2034년까지 CAGR 9.85%로 성장할 것으로 예측하고 있습니다.

신경외과용 장비는 중추신경계 및 말초신경계의 다양한 병태에 대한 수술 및 치료에 사용되는 다양한 기구 및 장치를 말합니다. 주로 파킨슨병, 알츠하이머병, 우울증, 간질, 외상성 뇌손상 및 척수손상 등의 질환의 진단, 예방, 치료에 사용됩니다. 일반적으로 사용되는 장비로는 신경자극기, 신경외과용 내비게이션 장치, 뇌척수액(CSF) 관리 장치(큐렛, 해부용 집게, 뼈 집게, 롱게일 등)가 있습니다. 이 기구들은 미세수술, 추간판 절제술, 측두근 하부 골막 박리, 수술 중 두개골 조정을 돕습니다.

전 세계적으로 다양한 신경질환의 유병률이 증가하고 있는 것이 시장 성장을 견인하는 주요 요인 중 하나입니다. 또한, 신경 질환 및 기타 의료 질환에 걸리기 쉬운 고령 인구의 증가도 시장 성장을 촉진하고 있습니다. 또한, 신경질환에 대한 효과적인 치료법 선택에 대한 일반인들의 건강 의식과 인식이 높아진 것도 시장 성장에 기여하고 있습니다. 그 결과, 기존의 뇌수술에 비해 신경내시경 수술이 점점 더 선호되는 추세입니다. 예를 들어, 다양한 신경자극기가 사용되며, 표적이 되는 천골신경에 전기적 자극을 주어 뇌심부자극을 시행하고 있습니다. 또한, 플로우다이버전, 액체색전 및 혈전제거 기기, 신경혈관내 스텐트, 풍선카테터 등 혁신적인 최소침습(MI) 기기의 개발을 포함한 다양한 기술 발전이 또 다른 성장 촉진요인으로 작용하고 있습니다. 의료 인프라 개선과 광범위한 연구개발(R&D) 활동을 포함한 다른 요인들도 시장을 더욱 견인할 것으로 예상됩니다.

본 보고서에서 답변하는 주요 질문:

  • 세계 신경외과용 의료기기 시장은 지금까지 어떻게 성장해 왔으며, 향후 몇 년 동안 어떻게 성장할 것인가?
  • 주요 지역 시장은 어디인가?
  • COVID-19가 세계 신경외과 기기 시장에 어떤 영향을 미쳤는가?
  • 제품 유형별 시장 현황은 어떻게 되는가?
  • 용도별 시장 현황은 어떻게 되는가?
  • 최종사용자별 시장 현황은 어떻게 되는가?
  • 산업 가치사슬의 각 단계는 무엇일까?
  • 업계의 주요 촉진요인과 도전 과제는 무엇인가?
  • 세계 신경외과용 의료기기 시장의 구조와 주요 기업들은 어떻게 구성되어 있는가?
  • 업계 내 경쟁의 정도는 어느 정도인가요?

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 신경외과용 의료기기 시장

제6장 시장 내역 : 제품 유형별

제7장 시장 내역 : 용도별

제8장 시장 내역 : 최종사용자별

제9장 시장 내역 : 지역별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter's Five Forces 분석

제13장 가격 분석

제14장 경쟁 구도

KSM

The global neurosurgery devices market size reached USD 14.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 33.1 Billion by 2034, exhibiting a growth rate (CAGR) of 9.85% during 2026-2034.

Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson's, Alzheimer's, depression, epilepsy and traumatic brain and spinal cord injury. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators and rongeurs. These tools aid in conducting microsurgeries, discectomies, elevating the periosteum below temporalis muscle and adjusting the skull bone during surgeries.

The increasing prevalence of various neurological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to neurological and other medical ailments, is also providing a boost to the market growth. There is also an increasing health consciousness and awareness among the masses regarding the availability of effective treatment alternatives for neurological disorders, which is contributing to the market growth. Consequently, there is a growing preference for neuroendoscopy surgeries over traditional brain surgeries. For instance, various neurostimulation devices are used to send electrical impulses to the targeted sacral nerves and perform deep brain stimulation. Additionally, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents and balloon catheters, are acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

  • Neurostimulation Devices
  • Neurointerventional Devices
  • Neurosurgical Navigation Systems
  • Cerebral Spinal Fluid (CSF) Management Devices
  • Others

Breakup by Application:

  • Spinal Cord Stimulation
    • Chronic Pain
    • Failed Back Surgery Syndrome
    • Ischemia
  • Deep Brain Stimulation
    • Parkinson's Disease
    • Tremor
    • Depression
    • Others
  • Neuroendoscopy
    • Transnasal Neuroendoscopy
    • Intraventricular Neuroendoscopy
    • Transcranial Neuroendoscopy

Breakup by End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Medtronic Plc, Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc., Stryker Corporation, etc.

Key Questions Answered in This Report:

  • How has the global neurosurgery devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global neurosurgery devices market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurosurgery devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurosurgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurostimulation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Neurointerventional Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Neurosurgical Navigation Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cerebral Spinal Fluid (CSF) Management Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Spinal Cord Stimulation
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Chronic Pain
      • 7.1.2.2 Failed Back Surgery Syndrome
      • 7.1.2.3 Ischemia
    • 7.1.3 Market Forecast
  • 7.2 Deep Brain Stimulation
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Parkinson's Disease
      • 7.2.2.2 Tremor
      • 7.2.2.3 Depression
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast
  • 7.3 Neuroendoscopy
    • 7.3.1 Market Trends
    • 7.3.2 Major Types
      • 7.3.2.1 Transnasal Neuroendoscopy
      • 7.3.2.2 Intraventricular Neuroendoscopy
      • 7.3.2.3 Transcranial Neuroendoscopy
    • 7.3.3 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Ackermann Instrumente GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Adeor Medical AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Braun Melsungen AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Biotronik
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Boston Scientific Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 DePuy Synthes Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Integra LifeSciences Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Johnson & Johnson Services Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Medtronic Plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Nevro Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Nihon Kohden Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Penumbra Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
    • 14.3.14 Stryker Corporation
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제